Advertisement

Acute Cancer Pain Syndromes in Palliative Care Emergencies

  • Sophia LamEmail author
  • Leeroy William
  • Peter Poon
Reference work entry

Abstract

Acute pain syndromes in palliative care are predominantly malignant in origin. These are often emergencies due to the severity of the pain, its meaning to the patient, the disruption of ongoing curative treatment, and the resultant erosion of quality of life. A prompt accurate pain assessment is a vital component of clinical management, followed by analgesic intervention and attention to the physical, psychological, social, and spiritual aspects of pain. Clinicians should develop excellent communication skills to support patients, their families, and also other healthcare professionals in the delivery of optimal care. Pain will not always be managed according to the expectations of others, and so how we deliver care and explain the limitations of treatment is important.

Acute cancer pain that is not managed well can become chronic in nature. The development of chronic pain can greatly reduce the functional ability and mood of patients over time. As with all symptoms, managing the acute presentation should lead to an investigation of causative factors, mechanism of pain, and potential therapeutic interventions. Acute pain syndromes can be approached via two causative mechanisms: treatment-related pain and pain directly related to the cancer process. A multimodal and multidisciplinary approach to treatment is often required to not only help the patient, but also to support the family during an uncertain and unsettling period of care.

References

  1. Ahmed SV, Jayawarna C, Jude E. Post lumbar puncture headache: diagnosis and management. Postgrad Med J. 2006;82(973):713–6.CrossRefGoogle Scholar
  2. Amini A, Yang J, Williamson R, McBurney ML, Erasmus J, Allen PK, Karhade M, Komaki R, Liao Z, Gomez D, Cox J. Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer. Int J Radiat Oncol Biol Phys. 2012;82(3):e391–8.CrossRefGoogle Scholar
  3. Ashby MA, Fleming BG, Brooksbank M, et al. Description of a mechanistic approach to pain management in advanced cancer: preliminary report. Pain. 1992;51:153–61.CrossRefGoogle Scholar
  4. Azevedo SLFK, Kimura M, Jacobsen-Teixeira M. The WHO analgesic ladder for cancer pain control, twenty years of use. How much pain relief does one get from using it? Support Care Cancer. 2006;14(11):1086–93. Epub 2006 Jun 8CrossRefGoogle Scholar
  5. Bilbao JI, Martínez-Cuesta A, Urtasun F, Cosín O. Complications of embolization. Semin Intervent Radiol. 2006;23(02):126–42.CrossRefGoogle Scholar
  6. Blinman P, Gainford C, Donoghoe M, Martyn J, Blomfield P, Grant P, Kichenadasse G, Vaughan M, Brand A, Shannon C, Gebski V. Feasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: an ANZGOG study. J Gynecol Oncol. 2013;24(4):359–66.CrossRefGoogle Scholar
  7. Bruera E, Kim HN. Cancer pain. JAMA. 2003;290(18):2476–9.CrossRefGoogle Scholar
  8. Carr DB, Goudas LC. Acute pain. Lancet. 1999;353:2051–8.CrossRefGoogle Scholar
  9. Chandra RV, Leslie-Mazwi T, Hirsch JA. Vertebroplasty, Kyphoplasty, and Sacroplasty. Essentials of interventional techniques in managing chronic pain. Cham: Springer; 2018. p. 431–42.CrossRefGoogle Scholar
  10. Cipta AM, Pietras CJ, Weiss TE, Strouse TB. Cancer-related pain management in clinical oncology. J Community Support Oncol. 2015;13:347–55.CrossRefGoogle Scholar
  11. Cohen AD, Kemeny NE. An update on hepatic arterial infusion chemotherapy for colorectal cancer. Oncologist. 2003;8(6):553–66.CrossRefGoogle Scholar
  12. Della Corte F, Messina A, Mendola C, Cammarota G. Post thoracotomy pain syndrome: InTech; Open Access Publisher; [online] from http://cdn.intechopen.com/pdfs/26930/InTech-Post_thoracotomy_pain_syndrome.pdf. 2012.Google Scholar
  13. Fadul N, Elsayem A. Palliative Care in the Emergency Center. In: Manzullo EF, Gonzalez CE, Escalante CP, Yeung S-CJ, editors. Oncologic emergencies. New York: Springer; 2016. p. 273–85.CrossRefGoogle Scholar
  14. Fischer DJ, Villines D, Kim YO, et al. Anxiety, depression, and pain: differences by primary cancer. Support Care Cancer. 2010;18(7):801–10.CrossRefGoogle Scholar
  15. Forbes K. Pain in patients with cancer: the World Health Organization analgesic ladder and beyond. Clin Oncol. 2011;23:379–80.CrossRefGoogle Scholar
  16. Fujiwara S, Komasawa N, Hyoda A, Kuwamura A, Kido H, Minami T. Ultrasound-guided sciatic nerve block (pulsed radiofrequency) for intractable cancer pain caused by sacral bone metastasis. Masui. 2015;64:663–5.PubMedGoogle Scholar
  17. Gutgsell T, Walsh D, Zhukovsky DS, et al. A prospective study of the pathophysiology and clinical characteristics of pain in a palliative medicine population. Am J Hosp Palliat Care. 2003;20(2):140–8.CrossRefGoogle Scholar
  18. Hart CYT, Ryu JH. Complications of percutaneous nephrostomy tube placement to treat nephrolithiasis. Hosp Physician. 2002;38(6):43–6.Google Scholar
  19. Hølen JC, Hjermstad MJ, Loge JH, Fayers PM, Caraceni A, De Conno F, et al. Pain assessment tools: is the content appropriate for use in palliative care? J Pain Symptom Manag. 2006;32:567–80.CrossRefGoogle Scholar
  20. Jackson MA, Simpson KH. Pain after amputation. Continuing education in Anaesthesia. Critical Care & Pain. 2004;4(1):20–3.Google Scholar
  21. Jacob LA, Sreevatsa A, Chinnagiriyappa LK, Dasappa L, Suresh TM, Babu G. Methotrexate-induced chemical meningitis in patients with acute lymphoblastic leukemia/lymphoma. Annals of Indian Academy of Neurology. 2015;18(2):206.CrossRefGoogle Scholar
  22. Kent ML, Tighe PJ, Belfer I, Brennan TJ, Bruehl S, Brummett CM, et al. The ACTTION–APS–AAPM pain taxonomy (AAAPT) multidimensional approach to classifying acute pain conditions. Pain med. Oxford University Press. 2017;18:947–58.Google Scholar
  23. Kerr JZ, Berg S, Blaney SM. Intrathecal chemotherapy. Crit Rev Oncol Hematol. 2001;37(3):227–36.CrossRefGoogle Scholar
  24. Kroenke K, Theobald D, Wu J, et al. The association of depression and pain with health-related quality of life, disability, and healthcare use in cancer patients. J Pain Symptom Manag. 2010;40:327–41.CrossRefGoogle Scholar
  25. Levy N, Sturgess J, Mills P. “Pain as the fifth vital sign” and dependence on the “numerical pain scale” is being abandoned in the US: why? Br J Anaesth. 2018;120(3):435–8. Available: https://www.sciencedirect.com/science/article/pii/S0007091217541823CrossRefGoogle Scholar
  26. Li BT, Wong MH, Pavlakis N. Treatment and prevention of bone metastases from breast Cancer: a comprehensive review of evidence for clinical practice. J Clin Med Res. 2014;3:1–24.CrossRefGoogle Scholar
  27. Lokich JJ, Moore C. Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome. Ann Intern Med. 1984;101(6):798–800.CrossRefGoogle Scholar
  28. Loprinzi CL, Reeves BN, Dakhil SR, Sloan JA, Wolf SL, Burger KN, Kamal A, Le-Lindqwister NA, Soori GS, Jaslowski AJ, Novotny PJ. Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. J Clin Oncol. 2011;29(11):1472–8.CrossRefGoogle Scholar
  29. Luckett T, Davidson PM, Green A, Boyle F, Stubbs J, Lovell M. Assessment and management of adult cancer pain: a systematic review and synthesis of recent qualitative studies aimed at developing insights for managing barriers and optimizing facilitators within a comprehensive framework of patient care. J Pain Symptom Manag. 2013;46:229–53.CrossRefGoogle Scholar
  30. Maltoni M, Scarpi E, Modonesi C, Passardi A, Calpona S, Turriziani A, et al. A validation study of the WHO analgesic ladder: a two-step vs three-step strategy. Support Care Cancer. 2005;13:888–94.CrossRefGoogle Scholar
  31. Margolese RG, Hortobagyi GN, Buchholz TA. Management of Metastatic Breast Cancer. In: Kufe DW, Pollock RE, Weichselbaum RR, et al., editors. Holland-Frei Cancer medicine. 6th ed. Hamilton: BC Decker; 2003.Google Scholar
  32. Matthews ML, Melika R, Murray Y. Nonopioid and adjuvant analgesics for acute pain management. Clinical approaches to hospital medicine. Cham: Springer; 2018. p. 225–41.Google Scholar
  33. McCarthy GM, Skillings JR. Jaw and other orofacial pain in patients receiving vincristine for the treatment of cancer. Oral surgery, oral medicine, oral pathology. 1992;74(3):299–304.CrossRefGoogle Scholar
  34. Mercadante S, Villari P, Ferrera P, Casuccio A, Fulfaro F. Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion. Cancer. 2002;95:203–8.CrossRefGoogle Scholar
  35. Metcalfe E, Etiz D. Early transient radiation-induced brachial plexopathy in locally advanced head and neck cancer. Contemp Oncol (Pozn). 2016;20(1):67–72.Google Scholar
  36. Neff SP, Stapelberg F, Warmington A. Excruciating perineal pain after intravenous dexamethasone. Anaesth Intensive Care. 2002;30(3):370–1.CrossRefGoogle Scholar
  37. Oefelein MG, Bayazit Y. Chronic pain syndrome after laparoscopic radical nephrectomy. J Urol. 2003;170:1939–40.CrossRefGoogle Scholar
  38. Pacenta HL, Kaddoum RN, Pereiras LA, Chidiac EJ, Burgoyne LL. Continuous tunnelled femoral nerve block for palliative care of a patient with metastatic osteosarcoma. Anaesth Intensive Care. 2010;38(3):563–5.CrossRefGoogle Scholar
  39. Pargeon KL, Hailey BJ. Barriers to effective cancer pain management: a review of the literature. J Pain Symptom Manag. 1999;18:358–68.CrossRefGoogle Scholar
  40. Pillitteri LC, Clark RE. Comparison of a patient-controlled analgesia system with continuous infusion for administration of diamorphine for mucositis. Bone Marrow Transplant. 1998;22(5):495–8.CrossRefGoogle Scholar
  41. Portenoy RK, Conn M. Cancer pain syndromes. In: Bruera ED, Portenoy RK, editors. Cancer pain: assessment and management. 2nd ed; 2009.Google Scholar
  42. Portenoy RK, Lesage P. Management of cancer pain. Lancet. 1999;353(9165):1695–700.CrossRefGoogle Scholar
  43. Porter LS, Keefe FJ. Psychosocial issues in cancer pain. Curr Pain Headache Rep. 2011;15:263–70.CrossRefGoogle Scholar
  44. Rahman NM, Pepperell J, Rehal S, Saba T, Tang A, Ali N, West A, Hettiarachchi G, Mukherjee D, Samuel J, Bentley A. Effect of opioids vs NSAIDs and larger vs smaller chest tube size on pain control and pleurodesis efficacy among patients with malignant pleural effusion: the TIME1 randomized clinical trial. JAMA. 2015;314(24):2641–53.CrossRefGoogle Scholar
  45. Rammohan A, Sathyanesan J, Ramaswami S, Lakshmanan A, Senthil-Kumar P, Srinivasan UP, et al. Embolization of liver tumors: past, present and future. World J Radiol. 2012;4:405–12.CrossRefGoogle Scholar
  46. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST. Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis. Cancer. 2004;100(S9):2026–46.CrossRefGoogle Scholar
  47. Sohn TA, Lillemoe KD, Cameron JL, et al. Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s. J Am Coll Surg. 1999;188:658.CrossRefGoogle Scholar
  48. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB. Perspectives on cancer therapy-induced mucosal injury. Cancer. 2004;100(S9):1995–2025.CrossRefGoogle Scholar
  49. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH. All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med. 1997;337(15):1021–8.CrossRefGoogle Scholar
  50. Thompson IM. Flare associated with LHRH-agonist therapy. Reviews in urology. 2001;3(Suppl 3):S10.PubMedPubMedCentralGoogle Scholar
  51. Vadalouca A, Moka E, Argyra E, Sikioti P, Siafaka I. Opioid rotation in patients with cancer: a review of the current literature. J Opioid Manag. 2008;4:213–50.CrossRefGoogle Scholar
  52. van den Beuken-van M, Hochstenbach L. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage: Elsevier; 2016. Available: http://www.sciencedirect.com/science/article/pii/S0885392416300483
  53. Vargas-Schaffer G. Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Physician. 2010;56:514–7. e202–5PubMedPubMedCentralGoogle Scholar
  54. Vial T, Descotes J. Clinical toxicity of cytokines used as haemopoietic growth factors. Drug Saf. 1995;13(6):371–406.CrossRefGoogle Scholar
  55. Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer. 2008;44(11):1507–15.CrossRefGoogle Scholar
  56. World Health Organization. Traitement de la douleur cancéreuse. Geneva: World Health Organization; 1987.Google Scholar
  57. Wu CL, Raja SN. Treatment of acute postoperative pain. Lancet. 2011;377(9784):2215–25.CrossRefGoogle Scholar
  58. Zeimet AG, Reimer D, Radl AC, Reinthaller A, Schauer C, Petru E, Concin N, Braun S, Marth C. Pros and cons of intraperitoneal chemotherapy in the treatment of epithelial ovarian cancer. Anticancer Res. 2009;29(7):2803–8.PubMedGoogle Scholar
  59. Zhu X-C, Zhang J-L, Ge C-T, Yu Y-Y, Wang P, Yuan T-F, et al. Advances in cancer pain from bone metastasis. Drug Des Devel Ther. 2015;9:4239–45.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of MedicineCairns and Hinterland Hospital and Health ServiceCairnsAustralia
  2. 2.Palliative Medicine, Monash Health, Eastern HealthMonash UniversityMelbourneAustralia
  3. 3.Supportive and Palliative Medicine, Monash Health, Eastern Palliative CareMonash UniversityClaytonAustralia

Personalised recommendations